18F-Labeled Fluoro-2-Deoxyglucose Positron Emission Tomography and Computed Tomography in a Large Pulmonary Sclerosing Pneumocytoma with Contralateral Lung Metastasis

Ranganath Thippanahalli Ganga; Mudalsha Ravina; Dibakar Sahu; Rakesh Kumar Gupta; Saroj Kumar Pati

doi:10.4103/ijnm.ijnm_90_21

¹⁸F-Labeled Fluoro-2-Deoxyglucose Positron Emission Tomography and Computed Tomography in a Large Pulmonary Sclerosing Pneumocytoma with Contralateral Lung Metastasis

Indian J Nucl Med. 2022 Jan-Mar;37(1):103-104. doi: 10.4103/ijnm.ijnm_90_21. Epub 2022 Mar 25.

Authors

Ranganath Thippanahalli Ganga¹, Mudalsha Ravina², Dibakar Sahu¹, Rakesh Kumar Gupta³, Saroj Kumar Pati⁴

Affiliations

¹ Department of Pulmonary Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
² Department of Nuclear Medicine,, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
³ Department of Pathology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
⁴ Department of Radiodiagnosis, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.

Abstract

Pulmonary sclerosing pneumocytoma is an exceedingly rare neoplasm of the lung. These tumors are usually slow growing with a benign disease course but can easily be mistaken for carcinoid tumors or adenocarcinoma in cytology or histopathology specimens. Rare occurrences of metastases have been reported in the literature making ¹⁸F-labeled fluoro-2-deoxyglucose positron emission tomography and computed tomography useful for the evaluation of these tumors.

Keywords: Fluoro-2-deoxyglucose positron emission tomography and computed tomography; pulmonary sclerosing hemangioma; pulmonary sclerosing pneumocytoma.